About the
Award
The Tom Reeve Award for Outstanding Contributions to Cancer Care, offered annually by COSA, formally recognises a national leader who has made significant contributions to cancer care.
The successful nominee will be presented with a Gold Marryalyan at the COSA Annual Scientific Meeting where they will be invited to deliver an address highlighting appropriate aspects of their area of professional interest.
Nominations are now open for the 2022 Tom Reeve Award for Outstanding Contributions to Cancer Care, closing Monday 1 August 2022.

Award eligibility & criteria
- have made significant contributions to cancer care through research, clinical leadership and/or community service
- have made substantial contributions over a relatively long period of time
- be nominated by a COSA member and have support from a member of COSA Council
- be an Australian resident
- an explanation of the nominee’s work in the area of cancer control or research
- an evaluation of the accomplishments of the nominee
- letters of reference from two individuals from outside the nominees’ institution (where applicable). These letters should contain a critical appraisal of the nominee’s work
Download the 2022 Tom Reeve Award Nomination form
Nominations and supporting documentation should be sent to cosa@cancer.org.au by COB Monday 1 August 2022.
Award recipients
One of Professor Barton's nominators said: “As a pioneer of academic radiation oncology in Australia, Michael has made, and is still making, outstanding contributions to clinical care, in oncological research, and cancer services policy throughout his career. He would be a very worthy recipient of the Tom Reeve Award.” And the COSA Board agrees.
Professor Barton will be well known to the COSA community. He is a clinical academic specialist Radiation Oncology at Liverpool Hospital, Cancer Therapy Centre and Research Director of the Collaboration for Cancer Outcomes Research and Evaluation (CCORE), who has dedicated his lifetime’s work to the improvement and innovation in the field of radiation oncology and cancer care.
Michael’s greatest contribution to radiation oncology in Australia and internationally may be considered his work in providing the evidence on which to base health policy and advising governments on frameworks for cancer services and then evaluating the impact of those services. A pivotal study was the determination from evidence-based treatment guidelines of the percentage of cancer patients who should receive radiation therapy at some time in their treatment, which enabled planning of radiation services.
Throughout his career he has mentored, educated and researched all the while providing excellent, team-based clinical care. This has provided an environment that has brought on another generation of researchers and provided clinical care in the more resource-challenged areas of Greater Sydney.
Michael initiated the Basic Science in Oncology Course (BSOC) which has continued to grow and thrive since its inception in the early 1990’s. Countless clinicians from a range of oncology and palliative care backgrounds have benefited from this work. Most recently, he brought together the three cancer streams through the Translational Cancer Research Centres (TCRC) at the University of New South Wales into a cohesive team working closely together on research and translation of research into clinical care.
Michael has written 42 commissioned reports for a wide variety of agencies on the delivery plans for various health jurisdictions, including the International Atomic Energy Agency (IAEA), the World Health Organisation (WHO), and the Global Taskforce for the use of Radiotherapy for Cancer Control (GTFRCC), an international collaboration to advise and plan for expansion of radiotherapy facilities around the world to better cater for the cancer needs of every country, especially those countries with serious health service delivery deficits. He chaired the Australian guidelines for the management of Adult Gliomas.
In terms of individual research output, as Research Director of CCORE he has been awarded over $20M in peer-reviewed funding. He has published 200 original scientific papers in peer-reviewed journals, 43 published abstracts, 9 editorials, 2 books, 15 book chapters, 8 electronic publications, and has over 9048 citation and an h-index of 46.
And the list goes on!
Professor Barton OAM was presented with the Tom Reeve Award and delivered his oration, during the 2021 COSA ASM on Wednesday 17 November. The presentation and oration are available for ASM delegates to view as recorded content.
Professor, Translational Cancer Research, Director, Sansom Institute for Health Research
Dean, Research Strategy, Division of Health Sciences, University of South Australia
Executive Director, Victorian Comprehensive Cancer Centre
COSA President 1992-93
COSA President 2021-22
Medical Oncologist, North Sydney’s Mater Hospital
Director of the Patricia Ritchie Centre for Cancer Care and Research
Professor of Medical Oncology, University of Sydney
COSA President 2006-June 2006
Professor, Palliative and Supportive Services, Flinders University
Chief Cancer Officer, New South Wales
Chief Executive Officer, Cancer Institute of New South Wales
COSA President 2000-01
Professor, Palliative and Supportive Services, Flinders University
Chief Cancer Officer, New South Wales
Chief Executive Officer, Cancer Institute of New South Wales
Chief Executive Officer and Director of Research, Translational Research Institute
Chair of Lung Cancer Service, Peter MacCallum Cancer Centre
COSA President 2017-18
Director of the Medical Psychology Research Unit, The University of Sydney
Professor of Surgical Oncology, University of Newcastle
Director of Research, School of Nursing and Midwifery, Queensland University of Technology
Professor of Radiology, University or Melbourne
COSA President 1981-83
Professor of Cancer Medicine, The University of Sydney
COSA President 1994-95
Chief Executive Officer, Cancer Council Australia
Executive Officer, the Australian Cancer Network
About Emeritus Professor
Tom Reeve AC CBE
Professor Tom Reeve AC CBE is Emeritus Professor in Surgery of the University of Sydney where he graduated in 1947. After working in Sydney and Queensland, he trained in General and Thoracic Surgery at Albany Medical College, New York. In 1958, the American Board of Surgery certified Professor Reeve and he became a Fellow of the Royal Australasian College of Surgeons in 1967. He was Chairman of Surgery at The University of Sydney from 1982-1988 and chaired the Northern Sydney Health Area from 1988-1996.
On retirement, Professor Reeve became President of the Royal Australasian College of Surgeons and Executive Officer of the Australian Cancer Network. In this role, Professor Reeve was involved in the development of Clinical Guidelines for the Management of Early Breast Cancer, the first evidence-based cancer management guidelines produced in Australia

Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 11 hours ago
🚨 Submit your #COSA22 abstract TODAY 🚨 Need a deadline to work to? Here it is! #COSA22 abstract submissions close MIDNIGHT AEST tonight!Last chance to finalise & submit ➡️ https://t.co/Pr91BEYqHH pic.twitter.com/OLsoPloe4P
Read More >
COSAoncology 23 hours ago
COSA members can make an impact on cancer control by subscribing to as many COSA Groups as they like! 🤝 Collaborate with COSA's multidisciplinary membership and contribute to Group activities.🖱️ Log in and update your preferences: https://t.co/WdMufywsoR pic.twitter.com/NLyeUlDJPU
Read More >
COSAoncology yesterday
We're looking for a proactive people person to enhance COSA member engagement & experience.The Membership Officer role is a part-time, flexible, 12 mth contract (with potential to renew). Contact us with Qs or apply now. Pls share with your networks! https://t.co/SMnzfElU80 pic.twitter.com/NZSTa5QtJA
Read More >
COSAoncology yesterday
Attention NSW and ACT researchers: expressions for the Enduring Cancer Data Linkage (CanDLe) program are now open. Details and applications: https://t.co/A1nLvVfQ0P pic.twitter.com/e6xKH2pUnn
Read More >
COSAoncology 2 days ago
With >30 #cancer #nurse leaders & our member organisations, our @ISNCC team has developed an international competency framework re. self-management support for ppl with cancer. —> https://t.co/3IiDfob6p7@CNSA_ORG @oncologynursing @CanoResearch #SelfMangement #survonc #supponc pic.twitter.com/FSjiIVqldp
Read More >
COSAoncology 2 days ago
📣 2 days left to submit your #COSA22 abstract.Finalise your oral & poster presentation abstracts and SUBMIT BY MIDNIGHT AEST THIS FRIDAY 12 AUGUST.We look forward to your innovative & important research.Submit at ➡️ https://t.co/Pr91BEYqHH pic.twitter.com/qIrq4ZDVOh
Read More >
COSAoncology 3 days ago
Cancer Australia welcomes the launch of 8 new Optimal Care Pathways (OCPs) for blood cancer. OCPs set national standards of blood cancer treatment and care. Find out more at https://t.co/hwmKxowvst #BloodCancer @LeukaemiaAus pic.twitter.com/BSmG21ENoz
Read More >
COSAoncology 3 days ago
💻 Our guidelines for fertility preservation for people with #cancer are live! 👶 Designed by HPs, for HPs, these guidelines will assist in discussing & managing fertility preservation for children, adolescents & adults of reproductive age @thewomens @ANZoncofert pic.twitter.com/oRkjkISLKc
Read More >
COSAoncology 3 days ago
Registrations are open for the @TOGAANZ 2022 Lung Cancer PreceptorshipAn active learning 2-day workshop 4 medical trainees & fellows to develop clinical knowledge & expertise in thoracic cancer mgmt & engage w mentors https://t.co/l8KHDxODex#LCSM pic.twitter.com/j8vmPpnOgF
Read More >
COSAoncology 4 days ago
AOMA Summit 2022 videos are now available to watch on the MASC Trials YouTube Channel. Featuring international and Australian experts in ocular melanoma as well as consumers.📺 https://t.co/cxbIK7d5Ga#Ocular #Uveal #Melanoma #AOMA22 #EyeCancer@AnthonyMJoshua @DrDamienKee pic.twitter.com/MD64Q1Bx7Q
Read More >